[About mechanism of interaction of phosphororganic inhibitors with cholinesterases of different origin].
D000085:Acetates / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D002802:Cholinesterases / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D004912:Erythrocytes / Q000201:enzymology; D017952:Ganglia, Invertebrate / Q000201:enzymology; D006736:Horses; D006801:Humans; D007215:Indophenol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D008974:Mollusca; D017553:Phosphorus Compounds / Q000737:chemistry / Q000494:pharmacology; D013045:Species Specificity
C468906:2,4-dichloroindophenyl acetate; D000085:Acetates; D002800:Cholinesterase Inhibitors; D017553:Phosphorus Compounds; D007215:Indophenol; C016519:indophenyl acetate; D002802:Cholinesterases
K mekhanizmu vzaimodeĭstviia fosfororganicheskikh ingibitorov s kholinésterazami razlichnogo proiskhozhdeniia.